Protective effect of phosphoenolpyruvate carboxykinase 1 on inflammation and fibrotic progression of IgA nephropathy
PCK1 exerted a pronounced inhibitory effect on mesangial cell inflammatory markers and fibrosis indicators in IgAN, potentially offering a novel therapeutic target for its treatment.
Authors
- Ying Tan (ORCID: https://orcid.org/0000-0002-8139-5758)
- Yonggui Wu (ORCID: https://orcid.org/0000-0001-6434-4759)
- Xue‐qi Liu (ORCID: https://orcid.org/0000-0002-5287-2471)
- Xiaomei Luo (ORCID: https://orcid.org/0000-0003-1524-2574)
- Xinran Liu (ORCID: https://orcid.org/0000-0001-6815-5322)
- Yu–Kai Wang (ORCID: https://orcid.org/0000-0001-8390-2664)
- Chaoyi Chen (ORCID: https://orcid.org/0000-0001-7732-6621)
Institutions
- Anhui Medical University (CN)
- Arkana Laboratories (US)
- First Affiliated Hospital of Anhui Medical University (CN)
Publication Details
- Journal
- Renal Failure
- Published
- 2025-05-29
- DOI
- https://doi.org/10.1080/0886022x.2025.2508297
- Citations
- 1
- Primary Topic
- Renal Diseases and Glomerulopathies
- Type
- article
- Field-Weighted Citation Impact
- 1.43